Physician

Jared Frisby, DO

According to 2025 Medicare claims, Jared Frisby, DO (NPI: 1649706243) practices infectious disease in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is METRO INFECTIOUS DISEASE CONSULTANTS, LLC (NPI: 1235125717; TIN: 363966745) and primary practice location at 64086-6001. Frisby is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Frisby's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 606 traditional Medicare patients, billed 105,531 HCPCS/CPT codes, and received $865,923 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 580 prescription claims across 144 beneficiaries totaling $640,698 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 1 records totaling $139. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,678 to $640,698. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$433K$866K2022 Medicare payment: $159,843 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $504,120 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $865,923 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202219711,325$159,843
2023542138,048$504,120
2024606105,531$865,923

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$320K$641K2017 Drug cost: $3,678 (USD; Tot_Drug_Cst)2018 Drug cost: $13,226 (USD; Tot_Drug_Cst)2019 Drug cost: $14,068 (USD; Tot_Drug_Cst)2020 Drug cost: $125,294 (USD; Tot_Drug_Cst)2021 Drug cost: $526,168 (USD; Tot_Drug_Cst)2022 Drug cost: $588,078 (USD; Tot_Drug_Cst)2023 Drug cost: $393,922 (USD; Tot_Drug_Cst)2024 Drug cost: $640,698 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201725104$3,678
201830266$13,226
201944329$14,068
202057385$125,294
202140328$526,168
202269347$588,078
2023114402$393,922
2024144580$640,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes335372$126
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more72124$95
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes322944$89
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less131708$46
J0875Injection, dalbavancin, 5 mg8536,550$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BiktarvyBictegrav/Emtricit/Tenofov Ala531,950$252,612
OdefseyEmtricitab/Rilpiviri/Tenof Ala18540$64,001
Isentress HdRaltegravir Potassium11330$21,244
ErtapenemErtapenem Sodium26171$14,890
DaptomycinDaptomycin24155$6,872

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$139Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jared Frisby, DO?

Tedicare shows public-source Medicare data for Jared Frisby, DO (NPI 1649706243), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jared Frisby, DO have ACO affiliation data?

Jared Frisby, DO is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Jared Frisby, DO?

Jared Frisby, DO is linked to METRO INFECTIOUS DISEASE CONSULTANTS, LLC (billing NPI 1235125717) in the available physician profile data.

Does Jared Frisby, DO have Open Payments data?

Jared Frisby, DO has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.